CSB-013(Tianjin CanSino Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCSB-013(Tianjin CanSino Biotechnology)
Drug Alias NameCSB-013
ClassificationVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsZika Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTianjin Cansino Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Cansino Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsZika Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A